$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000143774918020050 Filed on November 08, 2018

Income Statement

Concept	2018 Q3	2017 Q3
Revenue	$246.3M	$241.2M
YoY Change	2.13%	4.29%
Cost Of Revenue	$149.2M	$145.9M
YoY Change	2.26%	3.92%
Gross Profit	$97.10M	$95.30M
YoY Change	1.89%	4.84%
Gross Profit Margin	39.42%	39.51%
Selling, General & Admin	$10.20M	$10.10M
YoY Change	0.99%	-1.94%
% of Gross Profit	10.5%	10.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.50M	$10.80M
YoY Change	-2.78%	8.0%
% of Gross Profit	10.81%	11.33%
Operating Expenses	$85.10M	$84.20M
YoY Change	1.07%	6.18%
Operating Profit	$10.83M	$9.785M
YoY Change	10.72%	-7.6%
Interest Expense	$1.170M	$1.322M
YoY Change	-11.5%	29.61%
% of Operating Profit	10.8%	13.51%
Other Income/Expense, Net	$8.467M	$6.090M
YoY Change	39.03%	19.62%
Pretax Income	$22.79M	$15.88M
YoY Change	43.54%	1.24%
Income Tax	$1.700M	$4.691M
% Of Pretax Income	7.46%	29.55%
Net Earnings	$21.14M	$11.35M
YoY Change	86.24%	2.18%
Net Earnings / Revenue	8.58%	4.71%
Basic Earnings Per Share	$1.39	$0.75
Diluted Earnings Per Share	$1.39	$0.75
COMMON SHARES
Basic Shares Outstanding	15.23M	15.20M
Diluted Shares Outstanding	15.24M	15.22M

Balance Sheet

Concept	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$73.21M	$213.6M
YoY Change	-65.73%	28.52%
Cash & Equivalents	$55.60M	$69.79M
Short-Term Investments	$17.61M	$143.8M
Other Short-Term Assets	$31.00M	$28.00M
YoY Change	10.71%	-8.2%
Inventory	$7.590M	$7.113M
Prepaid Expenses
Receivables	$87.26M	$80.26M
Other Receivables	$3.500M	$7.100M
Total Short-Term Assets	$324.5M	$336.1M
YoY Change	-3.46%	17.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$540.9M	$552.3M
YoY Change	-2.07%	-0.95%
Goodwill	$21.00M	$17.60M
YoY Change	19.29%	0.0%
Intangibles
YoY Change
Long-Term Investments	$30.10M	$35.40M
YoY Change	-14.97%	-3.28%
Other Assets	$219.3M	$222.4M
YoY Change	-1.41%	-8.65%
Total Long-Term Assets	$760.2M	$774.7M
YoY Change	-1.88%	-3.29%
TOTAL ASSETS
Total Short-Term Assets	$324.5M	$336.1M
Total Long-Term Assets	$760.2M	$774.7M
Total Assets	$1.085B	$1.111B
YoY Change	-2.36%	2.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.60M	$14.70M
YoY Change	33.33%	-15.52%
Accrued Expenses	$86.30M	$81.00M
YoY Change	6.54%	3.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$151.5M	$147.6M
YoY Change	2.67%	3.37%
LONG-TERM LIABILITIES
Long-Term Debt	$75.00M	$120.0M
YoY Change	-37.5%	0.0%
Other Long-Term Liabilities	$14.70M	$15.54M
YoY Change	-5.4%	-4.12%
Total Long-Term Liabilities	$89.70M	$135.5M
YoY Change	-33.82%	-0.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$151.5M	$147.6M
Total Long-Term Liabilities	$89.70M	$135.5M
Total Liabilities	$363.5M	$419.3M
YoY Change	-13.33%	50.3%
SHAREHOLDERS EQUITY
Retained Earnings	$505.9M	$405.3M
YoY Change	24.84%	5.29%
Common Stock	$152.0K	$152.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$720.0M	$690.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.085B	$1.111B
YoY Change	-2.36%	2.07%

Cashflow Statement

Concept	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$21.14M	$11.35M
YoY Change	86.24%	2.18%
Depreciation, Depletion And Amortization	$10.50M	$10.80M
YoY Change	-2.78%	8.0%
Cash From Operating Activities	$27.70M	$30.70M
YoY Change	-9.77%	66.85%
INVESTING ACTIVITIES
Capital Expenditures	-$7.200M	-$7.600M
YoY Change	-5.26%	-47.22%
Acquisitions
YoY Change
Other Investing Activities	-$3.100M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$10.30M	-$7.600M
YoY Change	35.53%	-62.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.60M	-7.900M
YoY Change	135.44%	-50.63%
NET CHANGE
Cash From Operating Activities	27.70M	30.70M
Cash From Investing Activities	-10.30M	-7.600M
Cash From Financing Activities	-18.60M	-7.900M
Net Change In Cash	-1.200M	15.20M
YoY Change	-107.89%	-185.39%
FREE CASH FLOW
Cash From Operating Activities	$27.70M	$30.70M
Capital Expenditures	-$7.200M	-$7.600M
Free Cash Flow	$34.90M	$38.30M
YoY Change	-8.88%	16.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000
CY2018Q3	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1777000
CY2017Q3	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1696000
	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	5374000
	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	5319000
CY2018Q3	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	2222000
	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	2222000
	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	1753000
	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Percent EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsPercent	0.033
CY2018Q3	nhc	Effective Income Tax Rate Reconciliation Gain On Acquisition Of Equity Method Investment Amount Total EffectiveIncomeTaxRateReconciliationGainOnAcquisitionOfEquityMethodInvestmentAmountTotal	547000
	nhc	Effective Income Tax Rate Reconciliation Gain On Acquisition Of Equity Method Investment Amount Total EffectiveIncomeTaxRateReconciliationGainOnAcquisitionOfEquityMethodInvestmentAmountTotal	547000
CY2018Q3	nhc	Effective Income Tax Rate Reconciliation Provision To Return Adjustment Amount EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentAmount	1434000
	nhc	Effective Income Tax Rate Reconciliation Provision To Return Adjustment Amount EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentAmount	1434000
	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-159000
	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-1097000
CY2018Q3	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	109331000
CY2017Q4	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	108933000
CY2018Q3	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	5000
CY2017Q4	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	24000
CY2018Q3	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	2050000
CY2017Q3	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment
	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	2050000
	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment
	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	207000
	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	3630000
CY2018Q3	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	3818000
CY2017Q3	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4130000
	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	11265000
	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	11741000
CY2018Q3	nhc	Miscellaneous Revenue MiscellaneousRevenue	417000
CY2017Q3	nhc	Miscellaneous Revenue MiscellaneousRevenue	230000
	nhc	Miscellaneous Revenue MiscellaneousRevenue	996000
	nhc	Miscellaneous Revenue MiscellaneousRevenue	868000
	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	970000
	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	750000
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	nhc	Other Comprehensive Income Loss Securities Restricted Marketable Debt Securities Unrealized Holding Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossSecuritiesRestrictedMarketableDebtSecuritiesUnrealizedHoldingGainLossArisingDuringPeriodBeforeTax	2629000
CY2018Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	19611000
CY2018Q3	nhc	Number Of Assisted Living Facilities NumberOfAssistedLivingFacilities	24
CY2018Q3	nhc	Number Of Beds NumberOfBeds	9604
CY2018Q3	nhc	Number Of Geriatric Psychiatric Hospitals NumberOfGeriatricPsychiatricHospitals	1
CY2018Q3	nhc	Number Of Homecare Programs NumberOfHomecarePrograms	35
CY2018Q3	nhc	Number Of Independent Living Facilities NumberOfIndependentLivingFacilities	5
CY2018Q3	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	76
CY2018Q3	nhc	Other Comprehensive Income Loss Securities Restricted Marketable Debt Securities Unrealized Holding Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossSecuritiesRestrictedMarketableDebtSecuritiesUnrealizedHoldingGainLossArisingDuringPeriodBeforeTax	-180000
CY2017Q3	nhc	Other Comprehensive Income Loss Securities Restricted Marketable Debt Securities Unrealized Holding Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossSecuritiesRestrictedMarketableDebtSecuritiesUnrealizedHoldingGainLossArisingDuringPeriodBeforeTax	397000
	nhc	Other Comprehensive Income Loss Securities Restricted Marketable Debt Securities Unrealized Holding Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossSecuritiesRestrictedMarketableDebtSecuritiesUnrealizedHoldingGainLossArisingDuringPeriodBeforeTax	-3772000
CY2018Q3	nhc	Other Revenues OtherRevenues	11499000
CY2017Q3	nhc	Other Revenues OtherRevenues	11937000
	nhc	Other Revenues OtherRevenues	34256000
	nhc	Other Revenues OtherRevenues	34831000
	nhc	Primary Insurance Coverage Amount Per Incident PrimaryInsuranceCoverageAmountPerIncident	1000000
	nhc	Primary Insurance Coverage Amount Per Location PrimaryInsuranceCoverageAmountPerLocation	3000000
CY2018Q3	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
CY2017Q3	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
CY2018Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17596000
CY2017Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17389000
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	15978000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	60340000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	76943000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	88952000
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	87263000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86767000
CY2018Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	58487000
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	67102000
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	436437000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	409429000
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3692000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	67504000
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	217657000
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	215659000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1263000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1538000
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	361000
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	430000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1538000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1263000
CY2018Q3	us-gaap	Assets Assets	1084668000
CY2017Q4	us-gaap	Assets Assets	1096526000
CY2018Q3	us-gaap	Assets Current AssetsCurrent	324473000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	329311000
CY2018Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	73000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	823000
CY2018Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4746000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1705000
CY2018Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	172707000
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	167277000
CY2018Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	307536000
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	305480000
CY2018Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	202883000
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	197453000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	63282000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	77657000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	70331000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	87276000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	70157000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1200000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	797000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1198000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	796000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	19273000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18492000
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	19220000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18499000
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	168034000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	166395000
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	17606000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21012000
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	150428000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	145383000
CY2018Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3865000
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3696000
CY2018Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	20132000
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	23052000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	28167000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5200000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	2167000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	4170000
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	23997000
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55599000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59118000
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69790000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67421000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31589000
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67733000
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81740000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	312000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	50151000
CY2018Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2017Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.48
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.48
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.41
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15225654
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15212133
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15225654
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15212133
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	152000
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	152000
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21005000
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8931000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	37817000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	39786000
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-55000
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-168000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-249000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-349000
CY2018Q3	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2017Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	235492000
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	231411000
	us-gaap	Costs And Expenses CostsAndExpenses	692547000
	us-gaap	Costs And Expenses CostsAndExpenses	680642000
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
CY2018Q3	us-gaap	Customer Refundable Fees CustomerRefundableFees	8668000
CY2017Q4	us-gaap	Customer Refundable Fees CustomerRefundableFees	8827000
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	18000
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	255000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1067000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	881000
CY2018Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3892000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3226000
CY2018Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18648000
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18376000
CY2018Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5807000
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4867000
CY2018Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10437000
CY2017Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10833000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31176000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31609000
	us-gaap	Dividends Common Stock DividendsCommonStock	21419000
	us-gaap	Dividends Common Stock DividendsCommonStock	22530000
CY2018Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	7613000
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7297000
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31176000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31609000
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.075
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.295
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.195
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.361
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.019
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5728000
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.29
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.39
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.28
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3830000
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	7748000
CY2018Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	3486000
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	417000
CY2017Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss
CY2018Q3	us-gaap	Goodwill Goodwill	20995000
CY2017Q4	us-gaap	Goodwill Goodwill	17600000
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	22787000
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	15875000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	50355000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	53834000
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2724000
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2528000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1860000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5908000
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1700000
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4691000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9792000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19448000
CY2017	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-8488000
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	945000
CY2018Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2203000
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5465000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3319000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3857000
CY2017Q3	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	2077000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-613000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2273000
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-8615000
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-10326000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	666000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	645000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3262000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1248000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	437000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-395000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	262000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	7086000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1092000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-760000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1336000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	942000
	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	2668000
	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4375000
CY2018Q3	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1716000
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75000000
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100000000
CY2018Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	139502000
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	5362000
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	5721000
CY2018Q3	us-gaap	Interest Expense InterestExpense	1170000
CY2017Q3	us-gaap	Interest Expense InterestExpense	1322000
	us-gaap	Interest Expense InterestExpense	3663000
	us-gaap	Interest Expense InterestExpense	3599000
CY2018Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1916000
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1866000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5492000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	4820000
CY2018Q3	us-gaap	Inventory Net InventoryNet	7590000
CY2017Q4	us-gaap	Inventory Net InventoryNet	7153000
CY2018Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	30073000
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	36339000
CY2018Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	149188000
CY2017Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	145900000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	434749000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	426639000
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10190000
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10106000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30691000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30273000
CY2018Q3	us-gaap	Liabilities Liabilities	363450000
CY2017Q4	us-gaap	Liabilities Liabilities	393094000
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1084668000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1096526000
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	151548000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155065000
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	75000000
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	100000000
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2018Q3	us-gaap	Minority Interest MinorityInterest	1195000
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	139085000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	11352000
	us-gaap	Net Income Loss NetIncomeLoss	40812000
	us-gaap	Net Income Loss NetIncomeLoss	34735000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-349000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-249000
CY2018Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-55000
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-168000
CY2018Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1338000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1450000
CY2018Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	10031000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	11801000
CY2017Q4	us-gaap	Minority Interest MinorityInterest	694000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49664000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22034000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27090000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1190000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77066000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	70995000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	21142000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2018Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	10834000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	9785000
	us-gaap	Operating Income Loss OperatingIncomeLoss	38882000
	us-gaap	Operating Income Loss OperatingIncomeLoss	37787000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	287900000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	34200000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34200000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34200000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	34200000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	116900000
CY2018Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5548000
CY2017Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5500000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	16633000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	16501000
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	219259000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	217896000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5051000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2995000
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-137000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2421000
CY2018Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-7000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	17000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	18000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	255000
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4373000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	5751000
CY2018Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	64507000
CY2017Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	63250000
CY2018Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-36000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1572000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-795000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3074000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	192268000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	188522000
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16561000
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16194000
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14703000
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15795000
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8467000
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6090000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11056000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16047000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-376000
	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	176000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	867000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	22214000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	20943000
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	527000
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22708000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24328000
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	9950000
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	24874000
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3163000
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2864000
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;"><div style="display: inline; font-style: italic;">Prior Period Classifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;text-indent:36pt;">Certain amounts in prior periods have been reclassified to conform with current period presentation.</div></div></div>
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1180000
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3970000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1327000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1627000
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	970000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4539000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	46598000
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	4539000
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	46598000
CY2018Q3	us-gaap	Profit Loss ProfitLoss	21087000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3215000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	549319000
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	18000
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	255000
	us-gaap	Repayments Of Debt RepaymentsOfDebt	25000000
	us-gaap	Repayments Of Debt RepaymentsOfDebt
CY2017Q3	us-gaap	Profit Loss ProfitLoss	11184000
	us-gaap	Profit Loss ProfitLoss	40563000
	us-gaap	Profit Loss ProfitLoss	34386000
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	977373000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958748000
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	540936000
CY2018Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1098000
CY2017Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3121000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	982000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2751000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2591000
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	12134000
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11950000
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10209000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6397000
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1925000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1906000
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	505906000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	419423000
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;"><div style="display: inline; font-style: italic;">Deferred Revenue </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;text-indent:36pt;">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (“National”), the non-refundable portion (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div>) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers’ compensation and professional liability companies that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet earned.</div></div></div>
CY2018Q3	us-gaap	Revenues Revenues	246326000
CY2017Q3	us-gaap	Revenues Revenues	241196000
	us-gaap	Revenues Revenues	731429000
	us-gaap	Revenues Revenues	718429000
CY2018Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	95787000
CY2017Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	93275000
CY2018Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27815000
CY2017Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27409000
CY2018Q3	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	67972000
CY2017Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	65866000
	us-gaap	Share Based Compensation ShareBasedCompensation	1538000
	us-gaap	Share Based Compensation ShareBasedCompensation	1263000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.033
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.031
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.161
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.166
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.025
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	50000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1125443
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	110821
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5800000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	177959
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1239407
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1266702
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.19
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.79
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2535000
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	210881
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	63.35
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	51.25
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	51.25
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	72.96
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.40
CY2018Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1266702
CY2018Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	70.79
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y109D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y292D
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	720023000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	702738000
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48995
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	33526
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1627000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1327000
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	669611000
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	691489000
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	703432000
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	721218000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	867000
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div>
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15242086
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15220567
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15230692
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15217797
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15225654
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15195394
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15221217
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15186315

Files In Submission

Name	View Source	Status
0001437749-18-020050-index-headers.html	Edgar Link	pending
0001437749-18-020050-index.html	Edgar Link	pending
0001437749-18-020050.txt	Edgar Link	pending
0001437749-18-020050-xbrl.zip	Edgar Link	pending
ex_127324.htm	Edgar Link	pending
ex_127325.htm	Edgar Link	pending
ex_127326.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhc-20180930.xml	Edgar Link	completed
nhc-20180930.xsd	Edgar Link	pending
nhc-20180930_cal.xml	Edgar Link	unprocessable
nhc-20180930_def.xml	Edgar Link	unprocessable
nhc-20180930_lab.xml	Edgar Link	unprocessable
nhc-20180930_pre.xml	Edgar Link	unprocessable
nhc20180930_10q.htm	Edgar Link	pending
nhc20180930_10qimg001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2018 Q3 Form 10-Q Financial Statement

#000143774918020050 Filed on November 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2018 Q3 Form 10-Q Financial Statement

#000143774918020050 Filed on November 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc